&sq=&lang=&file=File:Translational_Research_Institute,_Wooloongabba.jpg) The Translational Research Institute | |
| Founder(s) | Professor Ian Frazer AC |
|---|---|
| Established | October 2013 |
| Mission | Medical research |
| Focus | Translational |
| Chief Executive Officer | Scott Bell |
| Faculty | |
| Adjunct faculty | Brisbane Diamantina Health Partners |
| Staff | 800 |
| Location | Kent Street, Woolloongabba , , , |
| Coordinates | 27°29′57″S 153°01′52″E / 27.499101°S 153.031221°E |
| Website | www |
The Translational Research Institute (TRI) is Australia's first translational medical research institute dedicated to translating scientific discoveries into applications for medical practice.[1]
Located in Woolloongabba, in inner-city Brisbane, Queensland, TRI is supported by a grant from the Australian Government ($140 million); and funding from the Queensland Government ($107 million); Queensland University of Technology ($25 million); and The University of Queensland ($10 million)[2] to combine clinical and translational research to advance progress from laboratory discovery to application in patient care.[3][4] TRI is a Pty Ltd. company with four shareholders: Queensland Health,[5] the Queensland University of Technology,[6] The University of Queensland[7] and Mater Medical Research.[8]
- ^ "Construction begins on Australia's first Translational Research Institute". Australian Trade Commission. Australian Government. Retrieved 16 August 2014.
- ^ "TRI Story". The University of Queensland. Retrieved 12 March 2017.
- ^ "TRI Story". The Translational Research Institute. Retrieved 12 March 2017.
- ^ "TRI Story". The University of Queensland. Retrieved 16 August 2014.
- ^ "Translational Research Institute". Queensland Government. Retrieved 16 August 2014.
- ^ "QUT Research Centres, Programs and Laboratories". Queensland University of Technology. Retrieved 16 August 2014.
- ^ "UQ TRI". The University of Queensland. Retrieved 12 March 2017.
- ^ "Mater Research - TRI". Mater Research. Retrieved 12 March 2017.